CON Approved for Tennessee Oncology

Bass, Berry & Sims served as lead counsel to Tennessee Oncology PLLC in its efforts to obtain a Certificate of Need (CON) to initiate state-of-the-art positron emission tomography (PET) services at a new practice location in fast-growing Williamson County, Tennessee. The project was unanimously approved by state regulators. PET is the key diagnostic tool used in oncology today. Tennessee Oncology’s new PET service will work in close collaboration with the Scott Hamilton Proton Therapy Center now under construction on an adjacent site.

Founded 40 years ago, Tennessee Oncology PLLC has grown to become one of the largest oncology medical groups in the United States. Its physician specialists deliver high quality patient care at dozens of practice locations and hospitals throughout the state. In partnership with the world-renowned Sarah Cannon Cancer Institute, Tennessee Oncology also is a national leader in clinical research.

You Also May Be Interested In:

  • Representation of Bravo Wellness, a national provider of employee wellness solutions and portfolio company of ABS Capital, in its sale to Medical Mutual, a health insurance company based in Ohio

    We represented Bravo Wellness, an ABS Capital portfolio company, in its sale to Medical Mutual, a health insurance company based...
    Client Type: Private Company
  • Representation of MyHealthDirect, a digital care coordination platform, in its sale to Experian Health

    We represented MyHealthDirect, a provider of digital care coordination platform that optimizes scheduling for providers, payers and consumers, in its...
    Client Type: Private Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company